Figures & data
Figure 1 Schematic diagram illustrating the cells entering process of anti-tumor nanometer preparation with CNTs as a carrier.
![Figure 1 Schematic diagram illustrating the cells entering process of anti-tumor nanometer preparation with CNTs as a carrier.](/cms/asset/6fe0e278-79ff-4c38-9065-002da18c6558/dijn_a_12191145_f0001_c.jpg)
Figure 2 This figure shows the sites that CNTs may accumulate after separation from anticancer drugs, resulting in toxicity to different organs. CNTs mainly cause damage and toxicity to organs such as heart, liver, lung, kidney, brain and embryo.
![Figure 2 This figure shows the sites that CNTs may accumulate after separation from anticancer drugs, resulting in toxicity to different organs. CNTs mainly cause damage and toxicity to organs such as heart, liver, lung, kidney, brain and embryo.](/cms/asset/8db88ed8-f63e-4406-91a7-31ad6d675efd/dijn_a_12191145_f0002_c.jpg)
Table 1 Toxicities of CNTs to Different Organs